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ABSTRACT 
A 3-(phenanthren-9-yl)-1H-indole-2-carboxylic acid (2) obtained from the cleavage of 
the methyl ester of the methyl 3-(phenanthren-9-yl)-1H-indole-2-carboxylate (1) was 
inserted into a peptide containing the RGD sequence. The GGRGDG peptide sequence 
was prepared by solid phase synthesis and coupled to compound (2), using 
diisopropylcarbodiimide (DIC) and 1-hydroxybenzotriazole (HOBt) in DMF. The 
peptide (3) labelled with the phenanthrenylindole moiety was obtained in 31% yield. 
The photophysical properties of the phenanthrenyl-indole derivatives were studied in 
several solvents of different polarity. Compounds 1 and 2 have reasonably high 
fluorescence quantum yields (between 27% and 85%) in non-protic solvents, the methyl 
phenanthrenyl-indole-2-carboxylate 1 being the more fluorescent compound. The 
fluorescence emission of both compounds is sensitive to solvent, indicating that they are 
good candidates for fluorescent probes. Fluorescence emission measurements of the 
labelled peptide in solution showed a strong decrease of ΦF value caused by the 
attachment of the Gly-Gly-Arg-Gly-Asp-Gly chain.  
The phenanthrenyl-indoles 1 and 2 and the labelled peptide 3 were incorporated in 
liposomes of dipalmitoyl phosphatidylcholine (DPPC) and dipalmitoyl 
phosphatidylglycerol (DPPG) and mixtures of both lipids. Steady-state anisotropy 
measurements showed that compounds 1 and 2 are located inside the lipid bilayers and 
are able to report the transition between the gel and liquid-crystalline phases. The RGD 
labelled peptide locates mainly in the outer part of the vesicle interface. These results 
indicate that the phenanthrenyl-indole moiety may be used as a fluorescent probe for 
peptides and lipid membranes. 
   
 
KEYWORDS: Phenanthrenyl-indole; RGD-peptide; Fluorescence; Lipid membranes 
 
 
ABBREVIATIONS. DPPC (dipalmitoyl phosphatidylcholine), DPPG (dipalmitoyl 
phosphatidylglycerol), PC (phosphatidylcholine), PG (phosphatidylglycerol), G 
(glycine), R (arginine), D (aspartic acid). 
 
 
 2 
1. INTRODUCTION 
Fluorescence spectroscopy is widely used to study proteins and peptides, with the vast 
majority of studies making use of the naturally occurring fluorophores, tyrosine and 
tryptophan. However, there is considerable interest in the incorporation of novel 
fluorophores, because they can offer site specific probes and, in many cases, can be 
chosen to allow selective excitation and detection [1-2]. Fluorescent peptides form a 
new generation of analytical tools for visualizing intracellular processes and molecular 
interactions at the level of single cells [3-4]. The sequence arginine–glycine–aspartic 
acid (RGD) (Figure 1) is found in many extracellular matrix proteins and is responsible 
for their interaction with a class of cell receptors known as integrins. These receptors 
are involved in the regulation of cellular proliferation and apoptosis. In particularly the 
integrin αvβ3 is over-expressed in some tumour cells and has been implicated in 
essential processes in the growth of solid tumours and in the development of metastases 
[5-9]. 
 
Figure 1. Tripeptide Arg-Gly-Asp. 
 
In our laboratories we have been interested in the synthesis of new heterocyclic 
compounds that could be used as fluorescent probes for biological systems [10]. One of 
the strategies developed for the synthesis of these compounds involves the Suzuki-
Miyaura cross-coupling of brominated dehydroamino acids with aryl boronic acids 
followed by a metal assisted C-N intramolecular cyclisation [11]. Using this 
methodology we were able to prepare a variety of indole derivatives and also to study 
their photophysical properties [10]. Among these compounds, the methyl 3-
(phenanthren-9-yl)-1H-indole-2-carboxylate was prepared and showed to be a good 
candidate to be used as a fluorescence probe for biological systems [10c]. Continuing 
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this work, it was decided to link this compound to a peptide containing the arginine-
glycine-aspartic acid (RGD) sequence.  
The absorption and emission properties of the methyl 3-(phenanthren-9-yl)-1H-indole-
2-carboxylate, 3-(phenanthren-9-yl)-1H-indole-2-carboxylic acid and of the labelled 
peptide were studied in both homogeneous solution and incorporated in lipid 
membranes of dipalmitoyl phosphatidylcholine and/or dipalmitoyl phosphatidylglycerol 
which are the main components of biological membranes. 
 
2. EXPERIMENTAL 
Materials and Methods 
Melting points (ºC) were determined in a Gallenkamp apparatus and are uncorrected. 1H 
and 13C NMR spectra were recorded on a Bruker Avance III at 400 and 100.6 MHz, 
respectively. 1H-1H spin-spin decoupling and DEPT θ 45º were used. HMQC and 
HMBC were used to attribute some signals. Chemical shifts are given in ppm and 
coupling constants in Hz. HRMS data were recorded by the mass spectrometry service 
of the University of Vigo, Spain.  
All the solutions were prepared using spectroscopic grade solvents and ultrapure water 
(Milli-Q grade). 1,2-Dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) and 1,2-
Dipalmitoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (sodium salt) (DPPG) were 
purchased from Sigma-Aldrich (lipid structures are shown below). 
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For phospholipid vesicles preparation, the injection method was used [10b,12-14]. 
Defined volumes of stock solutions of lipid (50 mM in ethanol for DPPC and 13.4 mM 
in tetrahydrofuran for DPPG) and compounds 1 and 2 (0.197 mM for 1, and 0.195 mM 
for 2) were injected together at 60 ºC, well above the melting transition temperature of 
DPPC (ca. 41 ºC) [15] and DPPG (39.6 ºC) [16], under vigorous stirring, to an aqueous 
buffer solution (10 mM Tris-HCl, pH=7.2) also at 60 ºC. In all cases, the final lipid 
concentration was 1 mM, with compounds/lipid molar ratio of 1:500. 
 
Spectroscopic measurements 
Absorption spectra were recorded in a Shimadzu UV-3101PC UV-Vis-NIR 
spectrophotometer. Fluorescence measurements were performed using a Fluorolog 3 
spectrofluorimeter, equipped with double monochromators in both excitation and 
emission, Glan-Thompson polarizers and a temperature controlled cuvette holder. 
Fluorescence spectra were corrected for the instrumental response of the system.  
For fluorescence quantum yield determination, the solutions were previously bubbled 
for 40 minutes with ultrapure nitrogen. The fluorescence quantum yields (Φs) were 
determined using the standard method (equation 1) [17,18]. 9,10-diphenylanthracene in 
ethanol (Φr = 0.95 [19]) was used as reference.  
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                (1) 
where A is the absorbance at the excitation wavelength, F the integrated emission area 
and n the refraction index of the solvents used. Subscripts refer to the reference (r) or 
sample (s) compound. The absorbance value at excitation wavelength was always less 
than 0.1, in order to avoid inner filter effects. 
Solvatochromic shifts were described by the Lippert-Mataga equation (2), which 
relates the energy difference between absorption and emission maxima to the 
orientation polarizability, [20,21] 
constf
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          (2) 
where absν  is the wavenumber of maximum absorption, flν  is the wavenumber of 
maximum emission, ∆µ = µe – µg is the difference in the dipole moment of solute 
molecule between excited (µe) and ground (µg) states, R is the cavity radius 
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(considering the fluorophore a point dipole at the center of a spherical cavity immersed 
in the homogeneous solvent), and f∆  is the orientation polarizability given by (eq. 3): 
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where ε is the static dielectric constant and n the refractive index of the solvent.  
The steady-state fluorescence anisotropy, r, is calculated by 
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where IVV and IVH are the intensities of the emission spectra obtained with vertical and 
horizontal polarization, respectively (for vertically polarized excitation light), and 
HHHV IIG =  is the instrument correction factor, where IHV and IHH are the emission 
intensities obtained with vertical and horizontal polarization (for horizontally polarized 
excitation light). 
 
Synthesis 
 
Synthesis of the methyl 3-(phenanthren-9-yl)-1H-indole-2-carboxylate (1): The 
synthesis of this compound was described elsewhere [10c]. 
 
Synthesis of 3-(phenanthren-9-yl)-1H-indole-2-carboxylic acid (2): A solution of 
NaOH 1M (3 equiv.) was added to a solution of 1 (0.6260 mmol; 0.220 g) in methanol 
(0.1 mol dm-3) and the mixture was heated at reflux. When all the reagent had been 
consumed (4 h) the methanol was removed and the solution was acidified to pH 1-2 
with HCl (5 mol.dm-3). Filtration of the solid formed afforded compound 2 (0.200 g, 
94%); m.p. 205-206 ºC. 1H NMR (400 MHz, CDCl3): 7.09 (t, J = 6.8 Hz, 1 H, ArH), 
7.29 (d, J = 8.4 Hz, 1 H, ArH), 7.36-7.45 (m, 3 H, ArH), 7.60-7.72 (m, 4 H, ArH), 7.79 
(s, 1 H, ArH), 7.87 (d, J = 8.4 Hz, 1 H, ArH), 8.77 (t, J = 7.6 Hz, 2 H, ArH), 9.18 (br s, 
1 H, NH) ppm. 13C NMR (100.6 MHz, CDCl3): 111.91 (CH), 121.04 (CH), 122.20 
(CH), 122.59 (CH), 122.73 (CH), 123.48 (C), 123.68 (C), 126.39 (CH), 126.46 (CH), 
126.47 (CH), 126.68 (CH), 126.73 (CH), 126.84 (CH), 128.73 (CH), 129.06 (C), 129.16 
(CH), 129.80 (C), 130.33 (C), 130.35 (C), 131.52 (C), 131.69 (C), 136.12 (C), 165.94 
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(C=O) ppm. HRMS (micrOTOF) [M+H]: calcd. for C23H15NNaO2 360.09950; found 
360.09938. 
 
Synthesis of peptide (3): The GGRGDG peptide was prepared by solid phase synthesis 
using a Fmoc strategy. Fmoc-Gly-OH (1.2 equiv.) and diisopropylethylamine (DIPEA) 
(4 equiv. relative to the amino acid) in dry dichloromethane (DCM) were added to the 
2-chlorotrityl chloride resin (0.5 g). The mixture was left stirring for 2h. At end of this 
time, the resin was washed with a mixture of DCM/MeOH/DIPEA (17:2:1) (3 × 20 mL), 
DMF (2 × 20 mL) and DCM (2 × 20 mL). The resin was dried in vacuum and the 
determination of the first residue attachment made by cleaving Fmoc with DBU and 
measuring the solution concentration of dibenzofulvene by UV spectroscopy. The 
loading amount was 0.58 mol.g-1. After cleavage of the Fmoc group with a solution of 
piperidine in DMF, couplings were carried out using an excess of the Fmoc-amino acid 
(4 equiv., 1.20 mmol) with diisopropylcarbodiimide (DIC) and 1-hydroxybenzotriazole 
(HOBt) in DMF. Compound 2 (0.58 mmol, 195.6 mg) was coupled to the last amino 
acid using a similar stategy. The peptide labelled with the phenanthrenylindole was 
cleaved from the resin using a mixture of acetic acid/1,1,1-trifluoroethanol/DCM (2:2:6). 
The protecting groups were removed with TFA to give peptide 3 as a yellow solid 
(150.5 mg, 31 %). 1H NMR (400 MHz, DMSO-d6): 11.97 (s, 1H, NH), 8.91 (t J=9.6 Hz, 
1H, ArH), 8.64 (brs, 1H, NH), 8.30-8.20 (m, 4 H, ArH+NH), 8.14-7.87 (m, 5H, 
ArH+NH), 7.75-7.64 (m, 4H, ArH+NH), 7.59-7.46 (m, 3H, ArH+NH), 7.29-6.94 (m, 
6H, ArH+NH3+), 4.59-4.56 (m, 1H, α-CH Asp), 4.28-4.22 (m, 1H, α-CH Arg), 3.84-
3.61 (m, 8H, CH2 Gly), 3.08-2.98 (m, 2H, δ-CH Arg), 2.67-2.52 (m, 2H, β-CH2 Asp), 
1.71-1.37 (m, 4H, β+γ CH2 Arg). 13C NMR (400 MHz, DMSO-d6): 24.77 (CH2), 28.84 
(CH2), 36.36 (CH2), 40.43 (CH2), 40.35 (CH2), 41.98 (CH2), 42.08 (CH2), 49.52 (CH), 
52.43 (CH), 42.40 (CH2), 112.50 (CH), 115.93 (C), 115.99 (C), 120.14 (CH), 120.33 
(CH), 122.83 (CH), 123.21 (CH), 124.16 (CH), 126.50 (CH), 126.55 (CH), 126.66 (CH), 
126.72 (CH), 126.91 (CH), 126.96 (CH), 128.70 (CH), 129.32 (CH), 129.80 (C), 130.09 
(C), 130.29 (C), 131.35 (C), 131.43 (C), 135.51 (C), 166.53 (C=N), 168.52 (C=O), 
168.68 (C=O), 168.77 (C=O), 170.92 (C=O), 170.98 (C=O), 171.04 (C=O), 171.75 
(C=O), 171.84 (C=O). HRMS (micrOTOF) [M+H]: calcd. for C41H45N10O10 837.33146; 
found 837.33039. 
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3. RESULTS AND DISCUSSION  
Synthesis 
The methyl 3-(phenanthren-9-yl)-1H-indole-2-carboxylate (1) [10c] was prepared from 
a β-bromodehydrophenylalanine and 9-phenanthracenylboronic acid by a Suzuki-
Miyaura cross-coupling followed by a Pd/Cu assisted C-N intramolecular cyclisation 
developed in our research group [10]. This compound was inserted into a peptide 
containing the RGD sequence after cleavage of the methyl ester (Scheme 1). Thus, 
compound 1 was treated with sodium hydroxide in methanol to afford the 
corresponding carboxylic acid (2) in a 94% yield. Compound 2 was conjugated with the 
hexapeptide glycine-glycine-arginine-glycine-aspartic acid-glycine (GGRGDG) 
synthesized by standard solid phase peptide synthesis (SPPS) using a 
fluorenylmethoxycarbonyl (Fmoc) protocol and a 2-chlorotrityl chloride resin. For side-
chain protection the 2,2,4,6,7-pentamethyl dihydrobenzofuran-5-sulfonyl (Pbf) group 
for arginine and the tert-butyl (tBu) group for aspartic acid were used. Coupling 
reactions were performed with diisopropylcarbodiimide (DIC) and 1-
hydroxybenzotriazole (HOBt). Compound 2 was coupled in solid phase using the same 
conditions. After cleavage from the resin and removal of the protecting groups, the 
labelled peptide 3 was obtained in 31% yield.  
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Scheme 1. Synthesis of compound 2 and peptide 3. 
 
Fluorescence of compounds 1 and 2 in several solvents 
The absorption and emission properties of compounds 1 and 2 were studied in ten 
solvents of different polarity. The maximum absorption (λabs) and emission wavelengths 
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(λem), molar absorption coefficients (ε) and fluorescence quantum yields (ΦF) are 
presented in Table 1. The normalized fluorescence spectra of the phenanthrenyl-indoles 
1 and 2 are shown in Figures 2 and 3, respectively. Examples of absorption spectra are 
shown as insets.  
 
Table 1 – Maximum absorption (λabs) and emission wavelengths (λem), molar absorption 
coefficients (ε) and fluorescence quantum yields (ΦF) for compounds 1 and 2 in several solvents. 
 
a
 Relative to 9,10-diphenylanthracene in ethanol (ΦF  = 0.95 at 25 ºC [19]). Error about 10%. 
b Solvents cut-off: Dimethylsulfoxide: 270 nm; N,N-Dimethylformamide: 275 nm; Ethyl acetate: 265 nm; 
Chloroform: 250 nm. 
 
In indole and its derivatives the near-ultraviolet absorption is generally attributed to two 
strongly overlapping π→π* transitions [22-24], with an average ε value for non 
substituted indole of 5550 M-1 cm-1, which also justifies its relatively high fluorescence 
quantum yield [25]. Compound 1 presents high ε values (ε > 1.2×104 M-1 cm-1) at the 
lowest energy maximum in all solvents studied, while for compound 2 the ε values are 
significantly lower (ε ≥ 3.9×103 M-1 cm-1) (Table 1). Many carbonyl compounds have a 
λabs (nm) (ε/104 M-1 cm-1) λem (nm) ΦF a Solvent 
1  2  1  2  1  2  
Cyclohexane 
298 (2.47), 
249 (6.27), 
226 (5.14) 
297 (0.39) 
252 (0.96) 
226 (0.76) 
399 397 0.70 0.28 
Dioxane 
298 (2.85)  
249 (6.97) 
226 (6.23) 
298 (0.65) 
249 (1.55) 
227 (1.35) 
400 400 0.49 0.48 
Ethyl acetate 297 (2.68) b  297 (0.65) b 400 403 0.85 0.33 
Dichloromethane 
298 (1.22) 
249 (2.94) 
226 (2.82) 
298 (0.51) 
250 (1.22) 
228 (1.03) 
404 410 0.80 0.34 
N,N-Dimethylformamide 299 (2.71) b  298 (0.57) b 405 412 0.63 0.42 
Dimethylsulfoxide 300 (2.61) b  299 (0.64) b 407 415 0.84 0.62 
Acetonitrile 
297 (2.25), 
248 (5.88), 
226 (4.64) 
297 (0.56) 
248 (1.39) 
225 (1.17) 
403 414 0.55 0.30 
Chloroform 299 (2.58) b 299 (0.69) b 410 412 0.85 0.27 
Ethanol 
298 (2.47), 
249 (6.26), 
227 (4.84) 
298 (0.77) 
248 (2.05) 
225 (1.85) 
417 410 0.57 0.11 
Methanol 
297 (2.55) 
248 (6.30) 
226 (5.10)  
298 (0.63) 
247 (1.73) 
225 (1.78) 
422 412 0.52 0.07 
Water 
297 (0.42) 
249 (0.75) 
226 (0.80) 
298 (0.71) 
251 (3.12) 
225 (1.70) 
426 431 0.02 0.09 
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low-lying n→pi* state, exhibiting low fluorescence quantum yields. As a carbonyl group 
is present in both compounds, the pi→pi* and n→pi* electronic transitions can be nearby 
in energy, resulting in state-mixing [26]. The high values of the molar absorption 
coefficient for compound 1 can indicate a predominance of the pi→pi* character, the 
latter being less pronounced for compound 2. 
 
Figure 2. Normalized fluorescence spectra of 2×10-6 M solutions of compound 1 in several 
solvents (λexc=325 nm). Inset: Absorption spectrum of 2×10-5 M solutions of 1 in cyclohexane 
and ethanol, as examples.  
 
 
For both compounds, significant red shifts are observed for emission in polar solvents, 
that are larger for compound 2, if alcohols are not considered. In the absorption spectra, 
the red shifts are negligible (Table 1), indicating that solvent relaxation after 
photoexcitation plays an important role. In polar solvents, a clear band enlargement in 
emission is also observed (Figs. 2 and 3), which is usually related to an intramolecular 
charge transfer (ICT) mechanism and/or to specific solvent effects [20]. This behavior 
was already observed in other indole derivatives previously synthesized by us, namely 
the methyl 3-arylindole-2-carboxylates [27], the 1-heteroaryl-3H-benzothieno or 
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benzofuroindole-2-carboxylates [28], and several heteroaryl and heteroannulated 
indoles [29].  
 
 
Figure 3. Normalized fluorescence spectra of 2×10-6 M solutions of compound 2 in several 
solvents (λexc=325 nm). Inset: Absorption spectrum of 2×10-5 M solutions of 2 in cyclohexane 
and ethanol, as examples.  
 
 
The Lippert-Mataga plots for compounds 1–2, shown in Figure 4, are reasonably linear 
in non-protic solvents, chloroform, alcohols and water exhibiting large positive 
deviations for the phenanthrenyl-indole 1. This behaviour can be due to specific solute-
solvent interactions by hydrogen bonds. Both compounds have the capability of 
hydrogen bonding formation through the NH group (donor) and the carbonyl group 
(acceptor). The formation of hydrogen bonds between chloroform and proton acceptors 
is known since a long time [31]. However, the Lippert-Mataga plot for compound 2 
shows a small negative deviation for alcohols. One possible explanation for this fact 
could be the formation, in the ground state, of a hydrogen bond between the H atom of 
the carboxylic group and alcohols that becomes weaker in the excited state. The same 
behaviour does not occur in water, that exhibits a usual large positive deviation for both 
compounds (Figure 4). The generally larger solvatochromic shifts for compound 2 point 
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to a higher ICT character of the excited state for this compound, due to the presence of a 
carboxylic acid group. 
 
Figure 4. Lippert-Mataga plots for compounds 1 and 2. Solvents: 1 - cyclohexane; 2 - dioxane; 
3 - chloroform; 4 - ethyl acetate; 5 - dichloromethane; 6 - dimethylsulfoxide; 7 - N,N-
dimethylformamide; 8 - ethanol; 9 - acetonitrile; 10 - methanol; 11 - water (values of ε and n 
were obtained from ref. [30]). 
From ab initio molecular quantum chemistry calculations, obtained with Gaussian 09 
software [32] and use of a 6-311+G(dp) basis set at the TD-SCF DFT (B3LYP) level of 
theory [33] in gas phase, the cavity radius (R) and the ground state dipole moment (µg) 
were determined for the two compounds (Table 2). The optimized geometry of the 
ground state of phenanthrenyl-indoles 1 and 2 shows that the indole-2-
carboxylate/carboxylic acid moiety is roughly perpendicular to the phenanthrene rings, 
while in the lower excited state a distortion occurs, with the approximation of the 
phenanthrenyl and indole moieties (Figure 5). The direction of the calculated dipole 
moments in the ground and excited state are also indicated. 
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Figure 5. Optimized geometries of compounds 1 and 2 obtained by Gaussian 09 software (grey: 
C atoms; white: H atoms; red: O atoms; blue: N atoms). Left: ground state; Right: lowest 
excited singlet state. The arrows indicate the direction of the dipole moment. 
 
The values of excited state dipole moments, estimated from the Lippert-Mataga plots 
and from molecular quantum mechanical calculations, are presented in Table 2. The 
values obtained from the calculations are slightly lower than the ones estimated from 
the Lippert-Mataga plots. Nevertheless, the µe values and the change in direction of the 
dipole moment (Figure 5) point to the presence of a significant charge transfer 
mechanism in the excited state, especially for the compound with the carboxylic group.  
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Table 2. Cavity radius (R) and ground state dipole moments (µg), obtained from theoretical 
calculations, and excited state dipole moments (µe) calculated from the Lippert-Mataga plots 
and from quantum mechanical calculations. 
Compound 
Cavity 
radius, R 
(Å) 
Ground state 
dipole moment, 
µg (D) 
Excited state dipole 
moment, µe (D), from 
Lippert-Mataga plots 
Excited state dipole 
moment, µe (D), from 
theoretical calculations 
1 5.7 2.81 7.2 6.9 
2 5.6 2.53 10.0 8.1 
 
 
Figure 6 displays the representation of HOMO and LUMO molecular orbitals for the 
two compounds, obtained with the calculated optimized geometries for ground and 
lowest excited singlet state. The HOMO molecular orbital is mainly located in the 
phenanthrenyl moiety, with a small contribution of the indole-2-carboxylate/carboxilic 
group, more significant for compound 1. The HOMO-LUMO transition (for both 
geometries) of these phenanthrenyl-indoles shows an almost complete charge transfer 
from the phenanthrene rings to the indole-2-carboxylate/carboxylic moiety. This 
confirms the CT character of the excited state, more pronounced for compound 2.  
 
 
Figure 6. Representation of HOMO and LUMO molecular orbitals of the phenanthrenyl-indoles 
1 (above) and 2 (below). Left: Optimized geometry for the ground state; Right: Optimized 
geometry for the lowest excited singlet state. 
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When in the excited state geometry, it is observed in LUMO molecular orbital of both 
compounds an additional electron density between the oxygen of the carbonyl group 
and a nearby double bond of the phenanthrenyl moiety. This is occurs as, due to the 
geometrical distortion, the distance between this oxygen atom and the C-C bond in the 
phenanthrenyl ring decreases from 3.7 Å to 2.7 Å. 
Figure 7 shows the representation of the energy level diagram with the transition 
energies of both compounds. The mentioned additional electron density is probably 
responsible for the significant decrease in LUMO energy upon geometrical relaxation of 
the excited state. These results predict a large Stokes’ shift that is, in fact, observed in 
the experimental data. The calculated absorption and emission transition energies are at 
lower energies than the ones experimentally observed. This can be due to solvent effects 
not accounted on the ab initio calculations as these were performed in the gas phase.   
 
Figure 7. Representation of the energy level diagram, with the transition energies for both 
compounds, obtained by molecular quantum chemistry calculations.  
 
Both compounds present reasonable to high fluorescence quantum yields in almost all 
solvents, compound 1 attaining 85% in some solvents (Table 1). A notable reduction of 
ΦF is observed for compound 2 in alcohols, probably caused by an increase of 
singlet→triplet intersystem crossing efficiency through H-bond interaction.  
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The generally high fluorescence quantum yields and solvent sensitive emission of 
compounds 1 and 2 make them good candidates as fluorescence probes for biological 
membranes and proteins, as they can be excited without simultaneous excitation of 
tryptophan and other aromatic amino acids (tyrosine and phenylalanine) of proteins, 
which absorb light at λ < 300 nm [20]. 
 
Fluorescence of peptide 3 in homogeneous solution 
Figure 8 shows the absorption (inset) and fluorescence spectra of the peptide 3 in 
ethanol and aqueous medium (pH = 7). A red shift (ca. 15 nm) and band enlargement is 
observed in aqueous media. Fluorescence quantum yields are presented in Table 3. It 
can be observed a strong fluorescence quenching of compound 1 caused by the 
attachment of a Gly-Gly-Arg-Gly-Asp-Gly chain. The high flexibility and length of the 
peptide chain leads to the increase of the non-radiative decay pathways (in particular, 
due to additional vibrational modes) and consequent decrease of ΦF values.  
 
Figure 8. Normalized fluorescence spectra (λexc=325 nm) of 2×10-6 M solutions of peptide 3 in 
ethanol and aqueous buffer (pH = 7). Absorption spectra of 2×10-5 M solutions in the same 
solvents are shown as inset. 
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Table 3. Maximum absorption (λabs) and emission wavelengths (λem), molar absorption 
coefficients (ε) and fluorescence quantum yields (ΦF) for peptide 3. 
 
a
 Relative to 9,10-diphenylanthracene in ethanol (Φ = 0.95 [19]) 
b
 Non-deoxygenated solution. 
 
A fluorescence study with variable pH (2−12) was also performed, to evaluate the 
potential of compound 1 to serve as fluorescent pH probe alone or when inserted in 
peptides. It was found that compound 1 alone presents a fluorescence emission 
insensible to pH (inset of figure 9). However, when linked to the peptide chain, 
significant variations in the fluorescence intensity can be detected (figure 9). Changes in 
the maximum emission wavelengths are negligible. The rise in the fluorescence 
intensity (inset of figure 9) starts at pH between 4 and 5. This variation can be related to 
the deprotonation of the side-chain carboxylic acid from the aspartic acid residue [34]. 
This could result in a hydrogen bond between the carboxylate anion and the indole 
group, affecting the peptide fluorescence quantum yield.  
 
Figure 9. Fluorescence emission spectra (λexc=325 nm) of 1×10-6 M solutions of peptide 3 in 
aqueous media of variable pH. Inset: Plots of emission intensity vs. pH for compound 1 alone 
(1×10-6 M) and linked to the peptide. 
Solvent λabs (nm) (ε/104 M-1 cm-1) λem (nm) ΦF a 
Ethanol 297 (0.25) 248 (0.60) 404 0.075
 
Aqueous buffer (pH =7) 297 (0.36) 247 (0.92) 423 0.038 
b
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Fluorescence of compounds 1-2 and peptide 3 in lipid membranes 
Photophysical studies of both compounds 1 and 2 and peptide 3 incorporated in lipid 
membranes composed of DPPC/DPPG mixtures were also performed. These two 
phospholipid molecules are the main components of biological membranes. It is known 
that, at room temperature, the neutral (zwitterionic) phospholipid DPPC (16:0 PC) and 
the anionic DPPG (16:0 PG) are in the ordered gel phase, where the hydrocarbon chains 
are fully extended and closely packed. Above the melting transition temperature, Tm= 
41 ºC [15] for DPPC and Tm= 39.6 ºC [16] for DPPG, lipid chains attain the disordered 
and fluid liquid-crystalline phase. 
The emission spectra of compounds 1 and 2 in lipid membranes of several DPPC/DPPG 
ratios at room temperature are displayed in Figure 10. At 55 ºC, the spectra in lipid 
membranes are very similar (data not shown) to those at lower temperature, with an 
expected fluorescence quenching (ca. 22% in neat DPPC and 45% in neat DPPG). In 
ethanol, the effect of increasing temperature (from 25 ºC to 55 ºC) in the fluorescence of 
these molecules is a ~ 42% reduction in intensity and a very small blue shift (1-2 nm for 
both compounds). 
The fluorescence spectra in lipid membranes are similar for both compounds, displaying 
a red shift with increasing DPPG content in the lipid membrane (Figure 10 and Table 4). 
As the difference between DPPC and DPPG molecules is only the polar head group, 
these results point to a higher hydration level of these compounds in DPPG rich vesicles. 
Another possibility for this behavior is the occurrence of hydrogen bonding between the 
compounds and the OH groups of DPPG polar head. 
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Figure 10. Normalized fluorescence spectra of compounds 1 and 2 (2×10-6 M) in lipid 
membranes of DPPC/DPPG (λexc=325 nm) at 25 ºC. 
 
 
Fluorescence anisotropy measurements (equation 4) can give further information about 
these molecules behaviour in lipid membranes [35]. The fluorescence steady-state 
anisotropies determined for compounds 1 and 2 in lipid membranes of DPPC/DPPG are 
shown in Table 4. Anisotropy values in glycerol at room temperature were also 
determined for comparison, being similar for both molecules. The largest anisotropy 
values are observed in neat DPPC at gel phase (25 ºC), that exhibits a melting transition 
temperature higher than DPPG.  
The fluorescence anisotropy values (Table 4) clear indicate that both compounds are 
mainly located inside the lipid bilayers. At 25 ºC (below the melting transition 
temperature of both lipids), the anisotropy of both molecules decreases monotonically 
with increasing DPPG content. The anisotropy values of both compounds are always 
higher in DPPC than in DPPG, the ratio rDPPC/rDPPG attaining ca. 1.5 times at 25 ºC. 
Although DPPG molecules have a lower transition temperature, the difference between 
Tm values of DPPC and DPPG is only 1.4 ºC. It is possible that some compound 
molecules are located in hydrated environments in DPPG, near the polar head groups, 
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justifying a further decrease in fluorescence anisotropy and the observed red shift in 
emission spectra. This behaviour is similar to that observed with a pyrenylindole-2-
carboxylate [10b]. 
At 55 ºC, when both phospholipids are at the liquid-crystalline phase, the anisotropy 
values of both compounds exhibit a significant reduction in all the lipid membranes, 
showing that these indolic derivatives clearly detect the phospholipid gel to liquid-
crystalline phase transition. 
Peptide 3 was also incorporated in the same lipid membranes. The emission spectra at 
25 ºC are presented in Figure 11 (the spectra at 55 ºC are similar in shape), and the 
fluorescence anisotropy values were also included in Table 4. Fluorescence spectra of 3 
in lipid vesicles are clearly composed of two bands, one with maximum near 405 nm 
and another with maximum near 420 nm. Attaining to the spectra obtained in ethanol 
and in water (Figure 8 and Table 3), these two bands can correspond to two different 
locations in liposomes, one in the lipid bilayer probably near the polar phospholipids 
head groups, and another in highly hydrated environments. The fluorescence anisotropy 
of the peptide in lipid membranes is also wavelength dependent and the r values 
presented in Table 4 are average values.  
 
Table 4. Steady-state fluorescence anisotropy (r) values and maximum emission wavelengths 
(λem) for compounds 1 and 2 and peptide 3 in mixed lipid membranes of DPPC/DPPG, below 
(25 ºC) and above (55 ºC) transition temperature of both lipids. Anisotropy values in glycerol at 
room temperature are also shown for comparison.   
1  2  Peptide 3 Lipid membrane 
composition T (ºC) λem (nm) r λem (nm) r λem (nm) r  
25 405 0.147 403 0.164 405 0.093 
Neat DPPC  
55 407 0.061 405 0.089 405, 425 sh 0.064 
25 406 0.131 405 0.145 405 0.078 
DPPC/DPPG 3:1 
55 408 0.061 407 0.078 406, 425 sh 0.050 
25 409 0.127 407 0.124 406, 425 sh  0.076 
DPPC/DPPG 1:1 
55 410 0.056 409 0.073 407 sh, 425 0.043 
25 411 0.109 411 0.120 408 sh, 420 0.071 
DPPC/DPPG 1:3  
55 410 0.045 413 0.062 408 sh, 420 0.040 
25 414 0.087 415 0.107 412 0.063 
Neat DPPG 
55 413 0.050 417 0.056 417 0.039 
Glycerol 25 398 0.320 397 0.327 398 0.332 
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Figure 11. Normalized fluorescence spectra of peptide 3 (2×10-6 M) in lipid membranes of 
DPPC/DPPG (λexc=325 nm) at 25 ºC. 
 
Due to this behaviour and considering the asymmetric nature of the peptide emission 
band (Figure 8), the fluorescence anisotropy components (IVV and G⋅IVH) were globally 
fitted to two sums of lognormal components (equations 5 and 6) [36], each sum 
characterized by a fitted anisotropy value, using a data analysis procedure previously 
developed by some of us [37], 
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where A (or A’) is the maximum intensity at wavelength λmax and the parameters a, b 
and c are given by [36] 
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where H is the half-width of the band and ρ is the skewness. The lognormal function 
sums account for the vibrational structure of compound spectrum. The components (1 
and 2) have two different fitted anisotropy values, r1 and r2, given by 
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Figure 12 displays an example of the fit of anisotropy components, IVV and G⋅IVH 
(equations 5 and 6), and the fitting to the anisotropy curve, as well as the respective 
spectral contributions recovered from the fitting. The results are given in Table 5. In all 
cases, two components were recovered, one with higher anisotropy (r1) and lower 
maximum emission wavelength (λ1,max) and another with higher emission wavelength  
(λ2,max) and very low anisotropy value (r2).  
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Figure 12. Fit of peptide 3 emission in DPPC/DPPG 3:1 lipid membranes (25 ºC). A: IVV 
component and fitted curve; B: G⋅IVH component and fitted curve; C: Recovered spectral 
components from the fitting procedure; D: Fluorescence steady-state anisotropy and recovered 
curve (calculated from the recovered components). 
 
Comparing the maximum wavelengths with the ones obtained for the emission in 
homogeneous solution (Figure 8 and Table 3), it can be concluded that component 1 
with λmax = 402−405 nm corresponds to an environment similar to ethanol. This is the 
minor component (10% − 16%), attaining ca. 30% fraction in DPPC. The high 
anisotropy value, r1, of this component points to a location inside the lipid bilayer, 
probably near the phospholipid polar head groups, feeling the transition to a more fluid 
phase at 55 ºC, above Tm of both DPPC and DPPG. In general, the microviscosity of a 
lipid bilayer decreases from the interface to the interior of the membrane [38,39].  
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Table 5. Steady-state fluorescence anisotropy (r) of the two anisotropy components, respective 
maximum emission wavelengths (λmax) and weight of the first component (f1) for peptide 3 in 
lipid membranes. Fluorescence quantum yields are also indicated. 
Lipid membrane 
composition T (ºC) f1 r1 
λ1,max 
(nm) r2 
λ2,max 
(nm)
 
ΦF a 
25 0.26 0.241 402 0.052 431 0.035 Neat DPPC 
55 0.31 0.142 402 0.033 432 0.013 
25 0.10 0.242 402 0.063 422 0.031 DPPC/DPPG 3:1 
55 0.12 0.164 402 0.035 422 0.015 
25 0.14 0.222 404 0.046 424 0.023 
DPPC/DPPG 1:1 
55 0.16 0.133 404 0.023 431 0.012 
25 0.11 0.191 402 0.066 421 0.030 DPPC/DPPG 1:3 55 0.12 0.116 404 0.028 432 0.017 
25 0.12 0.175 403 0.052 425 0.043 Neat DPPG 55 0.20 0.089 405 0.028 435 0.020 
a
 Relative to 9,10-diphenylanthracene in ethanol (Φ = 0.95 [19]) 
 
The major component, with maximum emission wavelength in the range 422−435 nm, 
corresponds to a hydrated environment, similar to pure water (Table 3). In fact, the 
anisotropy, r2, is very low, pointing to a very fluid medium. Therefore, the RGD 
labelled peptide locates mainly in the outer part of the vesicle interfaces, in a medium 
with a fluidity approaching that of water. The fluorescence quantum yields of the 
peptide in lipid membranes (Table 5) are in accordance with this conclusion, as the 
values at room temperature are similar to the one measured in pure water (Table 3). 
 
Conclusions 
The 3-(phenanthren-9-yl)-1H-indole-2-carboxylic acid (2) obtained from the cleavage 
of the methyl ester of the methyl 3-(phenanthren-9-yl)-1H-indole-2-carboxylate (1) was 
inserted in solid phase into a peptide containing the RGD sequence. The peptide was 
also prepared by solid phase synthesis using a Fmoc strategy and 2-chlorotrityl chloride 
resin.    
Both phenanthrenyl-indole derivatives 1 and 2, exhibit a solvent sensitive emission and 
generally high fluorescence quantum yields. The results point to the presence of a 
significant charge transfer mechanism in the excited state, especially for the compound 
with the carboxylic group. 
Fluorescence measurements of the labelled peptide in solution showed a strong decrease 
in the fluorescence quantum yield, but a pH sensitive emission was detected.  
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The phenanthrenyl-indole derivatives and the labelled peptide were incorporated in lipid 
membranes of DPPC and/or DPPG. Steady-state fluorescence anisotropy measurements 
revealed that both indolic compounds are located inside the lipid bilayers and are able to 
report clearly the transition between the gel and liquid-crystalline phases. The RGD 
labelled peptide locates mainly in the outer part of the vesicle interfaces. 
These results point to a promising utility of the phenanthrenyl-indole moiety as a 
fluorescence probe for biological systems, either as an extrinsic probe or as a label 
covalently bound to biomolecules. 
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